X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11) 11
animals (9) 9
humans (8) 8
mice (8) 8
pancreatic cancer (8) 8
article (7) 7
pancreatic neoplasms - pathology (7) 7
tumor microenvironment (7) 7
cancer (6) 6
carcinoma, pancreatic ductal - pathology (6) 6
immunotherapy (6) 6
adenocarcinoma (5) 5
carcinoma, pancreatic ductal - immunology (4) 4
disease models, animal (4) 4
enzyme-linked immunosorbent assay (4) 4
oncology (4) 4
pancreatic ductal adenocarcinoma (4) 4
pancreatic neoplasms - immunology (4) 4
stroma (4) 4
tumors (4) 4
carcinoma, pancreatic ductal - genetics (3) 3
ductal adenocarcinoma (3) 3
female (3) 3
flow cytometry (3) 3
gastroenterology & hepatology (3) 3
mice, inbred c57bl (3) 3
mice, transgenic (3) 3
pancreatic neoplasms - genetics (3) 3
pancreatic neoplasms - metabolism (3) 3
progression (3) 3
t-lymphocytes, regulatory - immunology (3) 3
abridged index medicus (2) 2
annexin a2 (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, neutralizing - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - pharmacology (2) 2
biochemistry & molecular biology (2) 2
blotting, western (2) 2
cancer associated fibroblast (2) 2
cancer vaccines - administration & dosage (2) 2
cancer vaccines - immunology (2) 2
carcinoma, pancreatic ductal - metabolism (2) 2
cell biology (2) 2
cells (2) 2
chemotherapy (2) 2
clinical trials (2) 2
clinical-significance (2) 2
digestive system diseases (2) 2
endocrine system diseases (2) 2
expression (2) 2
gemcitabine (2) 2
hedgehog protein (2) 2
heterografts (2) 2
immune checkpoint (2) 2
immunohistochemistry (2) 2
inhibition (2) 2
lymphocytes, tumor-infiltrating - drug effects (2) 2
metastases (2) 2
mice, 129 strain (2) 2
mouse model (2) 2
mutation (2) 2
pancreatic neoplasms - drug therapy (2) 2
pathways (2) 2
programmed cell death 1 receptor - antagonists & inhibitors (2) 2
regulatory t cells (2) 2
research paper (2) 2
stromal cells - metabolism (2) 2
tgf-beta (2) 2
transforming growth factor beta - antagonists & inhibitors (2) 2
tumor vaccine (2) 2
vaccine (2) 2
2,4-diaminoquinazoline derivatives (1) 1
3e (1) 1
activation (1) 1
acute lymphoblastic-leukemia (1) 1
adenocarcinomas (1) 1
adoptive transfer (1) 1
adult (1) 1
aged (1) 1
aged, 80 and over (1) 1
animal models (1) 1
annexin a2 - genetics (1) 1
annexin a2 - metabolism (1) 1
antibodies (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
anticancer properties (1) 1
antigens, neoplasm - immunology (1) 1
antineoplastic agents - therapeutic use (1) 1
antisense oligonucleotides (1) 1
antitumor activity (1) 1
antitumor immune-response (1) 1
apoptosis (1) 1
articles (1) 1
association (1) 1
autocrine communication - genetics (1) 1
b7-h1 (1) 1
b7-h1 antigen - antagonists & inhibitors (1) 1
bioindicators (1) 1
biology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. 4129 - 4129
Journal Article
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 3935 - 3935
Journal Article
Science, ISSN 0036-8075, 07/2017, Volume 357, Issue 6349, pp. 409 - 413
The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed... 
CELL LUNG-CANCER | SURVIVAL | COLORECTAL CARCINOMAS | RECEIVING NIVOLUMAB | IMMUNOTHERAPY | MICROSATELLITE INSTABILITY | MULTIDISCIPLINARY SCIENCES | LONG-TERM SAFETY | NEOANTIGENS | CHECKPOINT BLOCKADE | LYMPHOCYTES | Neoplastic Syndromes, Hereditary - immunology | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Neoplastic Syndromes, Hereditary - mortality | Young Adult | Colorectal Neoplasms - therapy | Brain Neoplasms - immunology | DNA Mismatch Repair | Aged, 80 and over | Adult | Female | Neoplastic Syndromes, Hereditary - genetics | Brain Neoplasms - mortality | Biomarkers, Tumor - antagonists & inhibitors | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, Neoplasm - immunology | Brain Neoplasms - genetics | Disease-Free Survival | Colorectal Neoplasms - immunology | Cell Cycle Checkpoints - drug effects | Brain Neoplasms - therapy | Neoplastic Syndromes, Hereditary - therapy | T-Lymphocytes - immunology | Aged | Mutation | Programmed Cell Death 1 Receptor - immunology | Colorectal cancer | Genetic aspects | Nucleotide sequencing | Health aspects | DNA repair | Methods | Tumors | DNA sequencing | Yeast | PD-1 protein | Antibodies | Clinical trials | Genomes | Functional analysis | Lymphocytes T | Patients | Survival | Colon cancer | Immune checkpoint | Immunotherapy | Mismatch repair | Pancreatic cancer | Biomarkers | Bioindicators | Colon | Solid tumors | Genetic recombination | Repair | Cancer | Apoptosis
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 01/2017, Volume 77, Issue 1, pp. 41 - 52
Journal Article
Journal of Gastrointestinal Oncology, ISSN 2078-6891, 06/2017, Volume 8, Issue 3, pp. 441 - 448
Pancreatic adenocarcinoma is still widely considered as a deadly disease even though there are substantial therapeutic developments in the past decade. Using... 
Pancreatic adenocarcinoma | Chemotherapy | Targeted therapy | Immunotherapy | targeted therapy | Review | chemotherapy | immunotherapy
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 7, pp. 1784 - 1794.e6
Background & Aims Premalignant lesions and early stage tumors contain immunosuppressive microenvironments that create barriers for cancer vaccines. Kras G12D/+... 
Gastroenterology and Hepatology | Tumor Microenvironment | Pancreatic Cancer | Listeria Vaccine | Immunity | MONOCYTOGENES | DUCTAL ADENOCARCINOMA | ONCOGENIC KRAS | CANCER | TUMORS | ADOPTIVE TRANSFER | IMMUNOTHERAPY | MOUSE MODEL | TC17 CELLS | SUPPRESSOR-CELLS | GASTROENTEROLOGY & HEPATOLOGY | Pancreatic Neoplasms - metabolism | Proto-Oncogene Proteins p21(ras) - genetics | Homeodomain Proteins - metabolism | Humans | Carcinoma, Pancreatic Ductal - metabolism | Interferon-gamma - metabolism | Mice, 129 Strain | Carcinoma, Pancreatic Ductal - genetics | T-Lymphocytes, Regulatory - immunology | Cancer Vaccines - therapeutic use | Carcinoma in Situ - genetics | Time Factors | Forkhead Transcription Factors - metabolism | Listeria monocytogenes - metabolism | Disease Models, Animal | Carcinoma in Situ - pathology | Antibodies, Monoclonal - pharmacology | Pancreatic Neoplasms - pathology | Mice, Transgenic | Disease Progression | Interleukin-17 - metabolism | Cyclophosphamide - pharmacology | Pancreatic Neoplasms - immunology | Mice | Mutation | Carcinoma in Situ - metabolism | T-Lymphocytes, Regulatory - metabolism | Carcinoma in Situ - drug therapy | Carcinoma in Situ - immunology | Listeria monocytogenes - immunology | Tumor Suppressor Protein p53 - genetics | Pancreatic Neoplasms - drug therapy | Inflammation Mediators - metabolism | Trans-Activators - genetics | Integrases - metabolism | Carcinoma, Pancreatic Ductal - immunology | Proto-Oncogene Proteins p21(ras) - metabolism | Mice, Inbred C57BL | Receptors, Chemokine - metabolism | Tumor Suppressor Protein p53 - metabolism | Pancreatic Neoplasms - genetics | Carcinoma, Pancreatic Ductal - pathology | Homeodomain Proteins - genetics | Cancer Vaccines - immunology | Carcinoma, Pancreatic Ductal - drug therapy | Animals | Listeria monocytogenes - genetics | Trans-Activators - metabolism | CD11b Antigen - metabolism | Integrases - genetics | Medical colleges | Vaccines | Listeria | Developmental biology | Pancreatic cancer | Contamination
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 11/2017, Volume 16, Issue 11, pp. 2399 - 2409
Journal Article
Human Molecular Genetics, ISSN 0964-6906, 10/2013, Volume 22, Issue 20, pp. 4074 - 4083
Journal Article
Gastroenterology, ISSN 0016-5085, 09/2019, Volume 157, Issue 3, pp. 838 - 850.e6
Little is known about mechanisms of perineural invasion (PNI) by pancreatic ductal adenocarcinomas (PDAs) or other tumors. Annexin A2 (ANXA2) regulates... 
Neuron-Derived Factors | Tumor Microenvironment | Motility | Pancreas | NERVOUS-SYSTEM | MECHANISMS | CANCER | SEMAPHORINS | COOPERATE | BIOLOGY | STROMA | GASTROENTEROLOGY & HEPATOLOGY | PARACRINE
Journal Article
Science Signaling, ISSN 1945-0877, 08/2015, Volume 8, Issue 388, pp. ra77 - ra77
Journal Article
HUMAN MOLECULAR GENETICS, ISSN 0964-6906, 10/2013, Volume 22, Issue 20, pp. 4074 - 4083
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 63, pp. 106405 - 106414
Pancreatic ductal adenocarcinoma (PDA) is renowned for high rates of metastasis and poor survival. Its notoriously dense fibrotic stroma contributes to... 
Stroma | Annexin A2 | Tumor microenvironment | Pancreatic cancer | CELLS | ADENOCARCINOMA | stroma | FIBROBLASTS | GEMCITABINE | CELL BIOLOGY | TRIAL | pancreatic cancer | TUMOR VACCINE | tumor microenvironment | ASSOCIATION | HYALURONIDASE
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.